Table 4.
Study | Population | P/R | Hemangioma | FNH | Cysts | Adenoma | FFS |
---|---|---|---|---|---|---|---|
% | |||||||
Massironi et al. [6] | Patient population (n = 1449) | R | 5.7 | – | – | – | – |
Khosa et al. [7] | Patient population (n = 1008) | R | 0.3 | – | 1.4 | – | – |
Kratzer et al. [8] | Normal population (n = 1624) | R | – | – | – | – | 9.1 |
Varbobitis et al. [9] | Normal population (n = 47,045) | R | 0.45 | – | 1.3 | – | – |
Rungsinaporn et al. [29] | Normal population (n = 3398) | R | 3.6 | – | 8.7 | – | – |
Linhart et al. [13] | Patient population (n = 731) | P | 5.7 | 0,8 | 10.2 | – | – |
Caremani et al. [22] | Patient population (n = 26 514) | R | – | – | 4.7 | – | – |
Strunk et al. [17] | Patient population (n = 166 with colorectal carcinoma) | R | 6.6 | – | 7.8 | – | 7.2 |
Gandolfi et al. [21] | Patient population (n = 21,280) | R | 1.4 | – | – | – | – |
Gaines et al. [23] | Patient population (n = 1695) | R | – | – | 2.5 | – | – |
P, prospective; R, retrospective; FNH, focal nodular hyperplasia; FFS, focal fatty sparing